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Abstract
During infection Neisseria meningitidis (Nm) encounters multiple environments within the host, which makes rapid
adaptation a crucial factor for meningococcal survival. Despite the importance of invasion into the bloodstream in the
meningococcal disease process, little is known about how Nm adapts to permit survival and growth in blood. To address
this, we performed a time-course transcriptome analysis using an ex vivo model of human whole blood infection. We
observed that Nm alters the expression of <30% of ORFs of the genome and major dynamic changes were observed in the
expression of transcriptional regulators, transport and binding proteins, energy metabolism, and surface-exposed virulence
factors. In particular, we found that the gene encoding the regulator Fur, as well as all genes encoding iron uptake systems,
were significantly up-regulated. Analysis of regulated genes encoding for surface-exposed proteins involved in Nm
pathogenesis allowed us to better understand mechanisms used to circumvent host defenses. During blood infection, Nm
activates genes encoding for the factor H binding proteins, fHbp and NspA, genes encoding for detoxifying enzymes such
as SodC, Kat and AniA, as well as several less characterized surface-exposed proteins that might have a role in blood survival.
Through mutagenesis studies of a subset of up-regulated genes we were able to identify new proteins important for
survival in human blood and also to identify additional roles of previously known virulence factors in aiding survival in
blood. Nm mutant strains lacking the genes encoding the hypothetical protein NMB1483 and the surface-exposed proteins
NalP, Mip and NspA, the Fur regulator, the transferrin binding protein TbpB, and the L-lactate permease LctP were sensitive
to killing by human blood. This increased knowledge of how Nm responds to adaptation in blood could also be helpful to
develop diagnostic and therapeutic strategies to control the devastating disease cause by this microorganism.
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Introduction
Neisseria meningitidis (Nm) is a Gram-negative commensal of the
human upper respiratory tract and asymptomatic carriage of Nm
in the nasopharynx is common in healthy adults. In susceptible
individuals, Nm can cause septicemia by crossing the mucosal
barrier and entering the bloodstream, or can cause meningitis by
crossing the blood–brain barrier and multiplying in the cerebro-
spinal fluid [1]. Invasive meningococcal infections represent a
major childhood disease with a mortality rate of 10% and high
morbidity in survivors [2]. During the transition from colonization
to an invasive bloodstream infection, Nm must adapt to changing
environments and host factors.
Sequencing of different Neisseria genomes has facilitated the
discovery of many previously unknown virulence factors [3-7] and
the comparison of disease and carrier strains has recently provided
new insights into the evolution of virulence traits in this species [6].
In order to better understand how Nm adapts to different
interactions with the host, it is necessary to study the gene
expression of the bacterium under conditions that approximate
the human niches it encounters in vivo. The interactions of Nm with
human epithelialand endothelial cells,as well as exposure to human
serum, have been analyzed using microarray expression studies,
which have provided useful information about the pathogenesis of
the bacterium and the function of previously unknown genes, and
have also enabled the identification of novel vaccine antigens [8].
However, little is known about how Nm adapts to permit survival
and growth in human whole blood, despite the importance of this
step in the disease process. An infant rat model of invasive infection
has been combined with a signature tagged mutagenesis (STM)
approach to identify genes essential for bacteremia [9]. However,
Nm is an exclusively human pathogen, and existing animal models
may not accurately simulate meningococcal disease. This justifies
the use of an experimental system that mimics, as closely as possible,
the in vivo situation seen during disease. Human whole blood has
been used as an ex vivo model of sepsis for studying the pathogenesis
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immunity [10–14]. Similar ex vivo models have also been used to
understand how pathogens, including Candida albicans, Listeria
monocytogenes, group A and group B Streptococcus species, regulate
gene expression during exposure to human blood [15–18].
In this study we have analyzed the global changes in the
transcriptional profile of a virulent Nm serogroup B (NmB) strain
in an ex vivo model of bacteremia, using incubation in human
whole blood and a time-course oligo-microarray experiment. This
approach revealed mechanisms used by Nm to adapt to human
blood, and was instrumental in analyzing the role of previously
known and newly identified virulence factors whose expression was
up-regulated during ex vivo infection.
Results and Discussion
Transcriptome analysis of Nm gene expression in an ex
vivo human whole blood model
In order to evaluate the transcriptional response of Nm during
growth in blood we used an ex vivo human whole blood model,
which enabled meningococcal responses to both host cellular and
humoral bactericidal mechanisms to be analyzed. This ex vivo
model has shown potential to examine a number of parameters
that are likely to be important in the cascade of events associated
with acute systemic meningococcal infection [19] and to chara-
cterize Nm factors involved in the survival of the bacterium during
infection [20,21]. Freshly isolated whole venous blood collected
from four healthy human volunteers (two male and two female)
was used. Bacterial loads in patients with fulminant disease can
reach up to 10
9 bacteria/ml [22–24]. Therefore, Nm MC58
bacteria (approximately 10
8, grown in GC medium to early
exponential phase) were mixed with blood from each donor in
order to mimic disease. Analysis of growth in the blood by colony
forming unit (CFU) counting showed that bacterial numbers
increased approximately 2-fold over a 90-minute incubation
period and that there was no significant difference in the number
of CFU between the four donors (Figure 1A).
In order to evaluate the adaptation of Nm to human blood,
samples were collected at six different time points (each time point
consisted of triplicate cultures): immediately after mixing bacteria
with blood (time 0, reference point), and after 15, 30, 45, 60 and
90 minutes incubation at 37uC. Total RNA extracted at each time
point consisted of a mix of eukaryotic and prokaryotic RNA
(Figure 1B). Since eukaryotic RNA can compete with bacterial
RNA during cDNA synthesis and fluorochrome labeling, we used
a procedure that simultaneously removes mammalian rRNA and
mRNA [25–27]. With this procedure, we were able to significantly
enrich the samples for Nm prokaryotic RNA (Figure 1B). We then
applied an in vitro transcription amplification/labeling step [28] to
produce amplified-labeled cRNA that was then used in compet-
itive hybridization experiments with a 60-mer Nm oligo-micro-
array. Transcriptional changes throughout the course of Nm
incubation in human blood were defined by comparison of
expression levels at various time points against time 0 (Figure 2A).
Variability between the four blood donors was quantified by
measuring the Pearson correlation coefficient ‘r’ between the
expression matrices of each pair of donors (r coefficients between
pairs of donor samples (i,j=1-4): r1-2=0.77, r1-3=0.78, r1-4=0.79,
r2-3=0.74, r2-4=0.87, r3-4=0.70). We also evaluated the Pearson
correlation ‘rijg’ at the level of each single gene ‘g’ and we
represented the distribution of the coefficients both globally and
between pairs of donors (Figure S1). This analysis showed an
excellent agreement between the gene expression profiles obtained
from the four donors. The four data sets were averaged in order to
obtain a single data set that was subsequently used to evaluate
global gene expression changes (Figure 2B).
Global changes in the Nm transcriptome during growth
in human blood
Analysis of the transcriptional profile of Nm grown in human
blood from four different donors over a 90 minute time course
revealed that a total of 637 genes were differentially regulated
during infection, which represents about 30% of the ORFs in Nm
genome. Genes were considered to be differentially regulated if they
showed, within donor replicas, an average transcript value of log2
ratio greater than 1 or less than 21 with a Student’s t-test p-value
Figure 1. Growth of Nm in human whole blood and RNA
analysis. (A) Number of bacteria during incubation with human blood.
The CFU/ml per single donor is shown during a time course experiment.
(B) Analysis of isolated total RNA and enriched Nm RNA using a
BioAnalyzer 2100 (Agilent). Upper panel: Total RNA collected from Nm
incubated in human whole blood, bacterial RNA (shaded arrowheads)
and eukaryotic RNA (open arrowheads) are indicated. Lower panel:
Enriched bacterial RNA.
doi:10.1371/journal.ppat.1002027.g001
Author Summary
Neisseria meningitidis (Nm) is an exclusively human
pathogen and a leading cause of bacterial meningitis
and septicemia worldwide. Characterization of the bacte-
rial transcriptome during host-pathogen interactions is a
fundamental step for understanding the infectious pro-
cesses of bacterial pathogens. Despite the severity of
meningococcal sepsis, little is known about how Nm
adapts to permit survival and growth in human blood. In
this work we report the transcriptional response of Nm
after incubation in human whole blood. The gene
expression results indicate that a significant part of the
ORFs of the genome (<30%) is differentially expressed
after incubation in human blood, with genes involved in
adaptation of Nm metabolism to blood and in virulence
and subversion of the host immune system being up-
regulated. Combining transcriptional analysis with the
generation and characterization of deletion mutants and
complementing strains, we identify new factors important
for survival in human blood. This first gene expression
analysis of Nm in blood significantly increases our
knowledge of how this bacterium responds to human
blood and causes septicemia. Our results also provide new
information on gene function and may ultimately help in
the development of diagnostic and therapeutic strategies
to control this devastating disease.
N. meningitidis Expression Profile in Human Blood
PLoS Pathogens | www.plospathogens.org 2 May 2011 | Volume 7 | Issue 5 | e1002027Figure 2. Global changes of Nm gene expression in human whole blood. (A) Experimental design. Human blood isolated from four different
donors was incubated with Nm and RNA extracted at the indicated time points (samples from each time point was done in triplicate and then
pooled). Time 0 was used as the reference time point. (B) Hierarchical clustering of the differentially expressed genes showing the data of the four
different donors (Donors 1–4) and the average dataset (Merge). Clustering showed two well defined partitions of the expression profiles, 360 up-
regulated (red) and 277 down-regulated genes (green). Genes were selected based on a fold change of at least two (log2 ratio ,21o r.1) and a t-
test p-value ,0.05. (C) Clusters of differentially expressed genes defined by the K-means algorithm and grouped based on the dynamics of expression
changes during the time course (black lines) and mean expression values of genes located in defined clusters (red lines). The number of genes
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infection, with respect to time 0. False discovery rate estimation was
performedbycalculating theq-values correspondingtoa thresholdof
t-test p-value of 0.05, and a range between 0.148 at time 15 min to
0.053 at time 90 min. Theconsequentnumberoffalse positivecalls,
using the |log2(ratio)|.1 cut-off, is relatively stable in each time
point and varies between 24 and 28 genes. The selection criterion
was also compared with the results obtained with BETR statistics,
which is specifically suitable to discover regulated genes during a
time course. The BETR algorithm confirmed 509/637 genes as
significantly (p-value ,0.05) regulated genes during the time course.
Interestingly, the subset of 128 genes, that are called as possible false
positives using the first statistical method, consist of genes strongly
regulated with rapidly changing behaviour over time or with blood
donor specificity. For this reason we still considered this subset as
interesting differentially expressed genes.
The expression profiles of the 637 selected genes were divided
into two well-separated groups by hierarchical clustering applied
to the expression matrix, with 360 genes up-regulated and 277
genes down-regulated compared to the reference time 0
(Figure 2B). Clusters of co-regulated genes were identified and
investigated by performing a Figure Of Merit (FOM) [29] analysis
using different clustering algorithms (see Methods). FOM analysis
showed that the value was stabilized after a partitioning into 7–10
clusters using all of the algorithms, but with particular quality
using the K-means method (FOMK-means is 4.4% to 22.2% less
than the FOM of the other clustering algorithms, data not shown).
Therefore, the expression profiles were split into 10 clusters
according to the K-means partitioning, each of which showed
particular expression profile dynamics (Figure 2C). For example,
clusters 1, 9 and 10 showed a rapid increase in expression within
15 minutes, after which time gene profiles reached a stable up-
regulation. Analogously, clusters 2 and 6 reached a stable down-
regulation within 15 minutes. Three additional clusters (5, 7 and 8)
reached a stable regulation after a delay of 30 minutes. However,
clusters 3 and 4 showed a different dynamic, genes showed up-
regulation (cluster 3) or down-regulation (cluster 4) at 15 minutes,
but expression levels were restored to the initial relative levels by
30–45 minutes.
Interestingly, gene expression profiles clustered by K-means
partitioning were modularly organized with respect to TIGRFAM
functional classes [30] or KEGG metabolic pathways and showed
a complete non-overlapping distribution (Table S2). These results
suggest that K-means clustering groups genes that are functionally
related, which could help in defining the function of un-annotated
genes. The genes present in each cluster and the TIGRFAM and
KEGG correlation results are reported in Table S1 and Table 2S,
respectively. The dynamics of gene expression within each
functional class was investigated by plotting the number of
regulated genes at each time point for each TIGRFAM class
(Figure 3). A wide range of hypothetical, unclassified ORFs and
ORFs with unknown function were differentially regulated.
Previous transcriptome analysis of Nm grown under various
conditions has aided in the functional characterization of
unclassified ORFs, including roles in cell adhesion [31] and
resistance to antimicrobial peptides [32]. Analysis of the
unclassified ORFs regulated in blood may aid in their functional
characterization. The major groups of differentially regulated
genes are involved in energy metabolism, transport and binding,
amino acid biosynthesis, regulatory functions, cellular processes
and cell envelope synthesis. These groups are predominantly up-
regulated, suggesting a high degree of metabolic adaptation occurs
in blood, enabling uptake of different substrates and induction of
alternative metabolic pathways. The differential distribution of the
number of up- and down- regulated genes within each TIGRFAM
class in the initial stages of the time course may indicate the main
roles involved in the adaptation process. Intriguingly, the equal
distribution of up- and down- regulated genes at 60 and 90
minutes in the majority of functional classes may suggest the initial
establishment of equilibrium in the gene expression of Nm
physiology.
In order to evaluate if the regulated genes identified areas a result
of growth phase changes and not growth in blood per se, we
performed microarray analysis of strain MC58 grown in laboratory
medium (GC liquid broth) at different time points matching the
ones used for analysis in blood (0, 30, 60 and 90 minutes). The
growth rate of MC58 (measured as CFU/ml) was comparable
between blood and GC (data not shown). The comparison of the
dataset generated in GC with the one generated in blood showed
that a subset of the differentially regulated genes (< 30%) are in
common between the two experimental conditions (Table S1). A
detailed analysis of these genes showed that they do not correlate
with any particular functional class (data not shown). However,
despite the fact that some regulated genes areincommon and might
result from growth phase changes, we decided to includeall genes in
the subsequent analysis because their altered expression in blood
indicates that they are involved in growth and fitness of the
meningococcusinthisenvironment.Tovalidatetheresultsobtained
in the microarray experiments in blood, quantitative real time PCR
(qRT-PCR)wasusedtoanalyze therelative expressionlevelsofnine
genes from different functional categories (NMB1030, NMB1870,
NMB2091,NMB2132,NMB1567,NMB1541,NMB0995,NMB1946
and NMB1898). Experiments were conducted using four biological
replicates (each comprising three technical repeats) comparing time
0 versus 45 minutes, using 16S rRNA for normalization. The
comparison of gene expression at 45 minutes measured by qRT-
PCR and microarrays analyses showed a significant Pearson
correlation between the two approaches (p-value ,0.01, r=0.98;
Figure S2B).
Several regulators are involved in Nm adaptation to
human blood
The expression of numerous regulators was altered during
incubation of Nm in human blood (Figure 4A). The ferric-uptake
regulation protein (fur, NMB0205), which is involved in the
regulation of Nm gene expression in response to iron concentra-
tion, was significantly up-regulated. Human blood, as well as other
body fluids, contains virtually no free iron because extracellular
iron is linked to high-affinity iron-binding proteins. The up-
regulation of Fur is indicative of iron-limitation, and led to altered
expression of several genes in the Fur regulon. In fact, half of the
83 genes regulated by Fur [33,34], were also differentially
regulated in blood with the same pattern of expression seen under
iron limitation and/or inactivation of Fur (data not shown).
Hfq (NMB0748), a RNA chaperone and key modulator of
riboregulation in bacteria, was also up-regulated during incuba-
tion in blood. The up-regulation of Hfq in blood suggests that non-
coding RNAs might also play a role in Nm infection as recently
reported for other bacterial pathogens [18,35]. Interestingly, the
Nm Hfq is involved in stress responses and virulence, with a hfq
included within each cluster is reported in blue between brackets. TIGRFAM main roles and KEGG pathways that significantly correlated with clusters
are reported in Table S2.
doi:10.1371/journal.ppat.1002027.g002
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attenuated in an infant rat model of bacteremia [9]. Further
analysis, using a similar ex vivo model and a tiling microarray, will
be instrumental to identify new Nm non-coding RNAs differently
expressed in human blood.
Several other transcriptional regulators were also differentially
regulated (Figure 4A), highlighting the high degree of regulation
that is required for adaptation of Nm to exposure and survival in
blood. In our study we did not observe regulation of the fnr gene
(NMB0380) coding for the Fumarate and Nitrate reductase
regulator protein, which is the major player in the metabolic
switch from aerobic to anaerobic growth and whose role in Nm
infection has been established [36]. However we observed that six
FNR-regulated genes were up-regulated (NMB0388, NMB1805,
NMB0577, NMB1677, NMB1623, NMB1870). This suggests that
while the level of expression of fnr does not change, the proportion
of active FNR is altered during growth in blood. In fact, human
blood is an oxygen-restricted environment, due to sequestration of
oxygen by hemoglobin, and FNR is expected to be in its active
dimerised form leading to increased expression of the FNR
regulon including AniA (NMB1623), a nitrite reductase that plays
a key role in anaerobic respiration [37].
Two-component regulatory systems (TCS) are one of the most
common bacterial signal transduction mechanisms controlling
responses and adaptation to environmental changes, and Nm has
four predicted TCS [4,7]: NMB0114/NMB0115, NMB0595/
NMB0594, NMB1249/NMB1250 and NMB1606/NMB1607. The
NMB0595 gene, which is part of the PhoQ, MisS/PhoP, MisR
TCS that has been extensively studied in Nm, was up-regulated
throughout the 90 minute time course, but particularly after 30
minutes The partner gene, NMB0594 coding for the sensor
histidine kinase, was slightly up-regulated at 15 minutes but not at
later time points. A meningococcal deletion mutant in the
NMB0595 gene displayed an attenuated virulence phenotype in
a mouse model of infection [38]. Moreover this TCS has been
shown to constitute a functional signal transduction system [39]
that modulates the meningococcal virulence factor, lipopolysac-
charide [40], and is required for optimal colonization of
endothelial cells [41]. On the other hand, NMB0114/NMB0115
(homologues of the NtrY/NtrX TCS) and NMB1250 (part of the
TCS that exhibits amino acid sequence similarity with NarQ/
NarP) were down-regulated. The TCS NMB1606/NMB1607 was
not differently regulated during the incubation in blood. The fact
that components of some TCSs were regulated differently may be
due to functional interaction and cross-regulation between the
TCSs [42] or may be related to the stability of the phosphorylated
states of the sensor or regulator and the consequent expression of
the genes [43].
Adaptation of Nm metabolism to human blood
The expression of a large proportion of genes involved in
nutrient transport and metabolic pathways was influenced by
incubation of Nm in human blood. This indicates a rapid
adaptation of the bacterial metabolism to specific nutrients, or
Figure 3. Time course distribution of up- and down- regulated genes within TIGRFAM main roles. The plot reflects the dynamics of Nm
metabolic adaptation to blood, and the number of regulated genes within each TIGR family is shown for each time point. The total number of genes
in each class and the number of up- and down-regulated genes are listed in the table.
doi:10.1371/journal.ppat.1002027.g003
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human blood. The ability of Nm to acquire iron plays an
important role in survival within the host, in terms of its ability to
replicate within cells [44] and survive in the bloodstream. Nm has
evolved numerous iron acquisition systems that enable it to use
transferrin, lactoferrin, hemoglobin and haptoglobin-hemoglobin
as iron sources [45] and several Nm mutants lacking these iron
uptake systems are attenuated in animal models [9,46]. In this
study, iron uptake systems along with the Fur regulator were found
to be significantly up-regulated (Figure 4B). Genes encoding the
transferrin binding proteins (tbpA and tbpB), lactoferrin binding
proteins (lbpA and lbpB) and the hemoglobin receptor (hmbR) were
Figure 4. Transcriptional profile of differentially regulated genes grouped by functional TIGRFAM family main roles. Detailed
expression profiles of functionally related genes during the time course of Nm in human whole blood. Clusters were created using TMEV. (A)
Regulatory functions (B) Transport and binding proteins (C) Energy metabolism (D) Amino acid biosynthesis. Each gene is represented by a single
row and each time point by a single column; gene identification numbers (based on the MC58 annotation) and gene definitions are reported on the
right. Gene expression is displayed in fold change represented by the color bar under the figure. The numerical gene expression values are shown for
all the genes at the different time points. For a more detailed analysis, see Table S1.
doi:10.1371/journal.ppat.1002027.g004
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encoding for the systems involved in the transport of iron through
the periplasm: fbpA (NMB0634) and tonB/exbB/exbD (NMB1728-
NMB1730) (Figure 4B). Interestingly, strains with mutations in
genes encoding for TonB, ExbB and ExbD have an attenuated
phenotype in the infant rat model of Nm infection [9]. Genes
encoding for the iron storage protein bacterioferritin (NMB1206/
NMB1207) were down-regulated suggesting the necessity for Nm
to utilize iron rather than to store it.
Nm can use lactate and glucose as carbon and energy sources,
and both compounds are present in human blood [47]. In our
study, genes involved in the uptake of glucose (gluP, NMB0535)
and lactate (lctP, NMB0543) were significantly up-regulated
(Figure 4B). Nm catabolizes lactate at a faster rate than glucose
and LctP has been shown to be involved in virulence: a lctP mutant
has a reduced growth rate in cerebrospinal fluid and was
attenuated in a mouse model of infection due to increased sensi-
ftivity to complement-mediated killing [48]. Also in the functional
class of ‘transport and binding proteins’ we found the up-
regulation of genes NMB0318–NMB0319 that are annotated as
fatty acid efflux system proteins and are homologues of the farAB
system of N. gonorrhoeae, which are involved in resistance to
antibacterial fatty acids [49]. Interestingly, the other system known
to be involved in antimicrobial resistance, mtrCDE (NMB1714/
NMB1715), was down-regulated. This different regulation in
expression of the antimicrobial systems may be indicative of their
specific roles in particular niches within the host. Genes encoding
for sulfate, spermidine/putrescine, amino acid, sodium and
magnesium transporters were also down-regulated (Figure 4B).
Nm adapted its energy metabolism during incubation in blood,
with genes in both aerobic and anaerobic metabolic pathways
being regulated. The classification of the up- and down-regulated
genes in TIGRFAM sub-roles gave a clear picture of the pathways
involved in this adaptation (Figure 4C and Figure S3). We
observed up-regulation of genes encoding enzymes involved in
glycolysis (pgi-1, fbp, pgm, tpiA) and the citric acid cycle (pprC, acnA,
icd, sdhC, sdhD, sdhB, gltA, sucC, sucD, fumC, acnB, fumB, yojH). Genes
encoding for fermentation enzymes were also up-regulated,
including genes in a putative 2-methylcitrate pathway (NMB0430
-NMB0433), which has been shown to be present only in
pathogenic Neisseria species [50]. Several genes involved in the
biosynthesis and assembly of components of the respiratory chain
were also differentially regulated (Figure 4C and Figure S3).
Genes included in the TIGRFAM main role ‘amino acid
biosynthesis’ were induced in blood, in particular genes involved in
glutamate metabolism, indicating that this amino acid may be
important nutrient source for Nm in blood (Figure 4D and Figure
S3). Indeed, there is evidence that L-glutamate uptake from the
host is critical for Nm infection: gltT (ABC-type L-glutamate
transporter) is essential for meningococcal survival in infected cells
and for the establishment of infection in mice [51]; gdhA (glutamate
dehydrogenase) was found to be important for Nm survival in
STM analysis [9] and is hyper-expressed in Nm invasive isolates
[52]. The fact that gdhA (NMB1710) is strongly up-regulated in
human blood confirms the important role played by this enzyme
in Nm infection. Additionally, genes involved in pyruvate
metabolism, which is part of the protein synthesis pathway, were
also up-regulated (Figure 4D and Figure S3).
Regulation of Nm genes involved in host-pathogen
interaction
Nm has evolved to produce an array of molecules to colonize,
infect and survive in the hostile microenvironments of the host
[1,53]. A list of genes involved in the mechanisms by which Nm
interacts with the host and subverts host defenses is shown in
Figure 5. Several genes encoding for molecules with documented
or predicted adhesive properties were up-regulated in human
blood including, opa (NMB1636) and opc (NMB1053), the gene
encoding for AusI/MspA (a phase-variable autotransporter
involved in the interaction of Nm with human epithelial and
endothelial cells [54,55]), and the genes encoding for MafA
proteins (NMB0375 and NMB0652; homologues of glycolipid-
binding adhesins characterized in N. gonorrhoeae [56]). Transcrip-
tion of genes coding for NhhA (NMB0992), NadA (NMB1994) and
App (NMB1985), three Nm adhesins involved in interactions with
epithelial cells [57–59], were not significantly altered during the
time course of infection. Also genes coding for pili proteins were
not differentially regulated. This might suggest that these factors,
which are important for adhesion and colonization, might not be
essential during survival in blood.
It is interesting to note that a subset of the genes encoding for
surface-exposed adhesins were up-regulated in human blood,
suggesting that in addition to their main role in interaction with
host tissues, these factors might also be involved in the interaction
with blood cells or in the survival in whole blood. For example,
Opa and Opc proteins have been reported to have a role in the
interaction of Nm to human monocytes [60].
In order to neutralize the effect of reactive oxygen and nitrogen
species produced by neutrophils and macrophages, Nm uses
enzymes such as catalase, superoxide dismutase and enzymes
capable of denitrification [61,62]. In this study Nm up-regulated
the genes coding for catalase (kat, NMB0216), superoxide
dismutase C (sodC, NMB1398) and nitrite reductase (aniA,
NMB1623). Interestingly, SodC has been shown to protect Nm
from phagocytosis [63] whereas AniA has also been shown to
provide protection to N. gonorrhoeae in human sera [64], two
important phenotypes in the context of growth in human blood.
The NMB1567 gene was also highly up-regulated in blood, which
encodes for a homologue of the N. gonorrhoeae Mip (Macrophage
Infectivity Potentiator) protein that is involved in intracellular
survival and persistence [65].
Nm expresses several surface molecules responsible for effective
bacterial defense against human complement. The capsule
prevents insertion of the MAC complex into the bacterial outer
membrane, while other surface-exposed proteins recruit negative
regulators of the complement system such as C4BP and factor H
(fH) [66]. Genes involved in capsule biosynthesis were not
differentially regulated during the transition from liquid medium
to growth in human blood. Similarly, expression of the porA gene
(NMB1429) encoding for the most abundant outer membrane
protein of Nm, which is involved in interaction with C4BP [67],
was not significantly altered in blood. However, we observed up-
regulation of the fHbp gene (NMB1870), which encodes a surface-
exposed lipoprotein able to bind fH and enhance the ability of Nm
to multiply and survive within blood [21,68]. The up-regulation of
fHbp in human blood supports previous reports of the crucial role
of this protein during Nm pathogenesis. It has been recently shown
that the fHbp protein is expressed from two independent
transcripts: one bicistronic transcript that includes the upstream
gene (NMB1869), and a second shorter monocistronic transcript
from a FNR-dependent promoter [69]. The upstream NMB1869
gene was not up-regulated suggesting that the up-regulation of
fHbp occurs through its own promoter. NspA (Neisseria surface
protein A, NMB0663) was highly up-regulated throughout the time
course of infection. It has been recently reported that NspA is also
able to bind fH and enhance resistance to human complement
[70]. In this context, up-regulation of the nspA gene highlights the
important role that this protein is expected to play in survival.
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of interest were differently regulated; the gene encoding for
autotransporters NalP (NMB1969, [71]), IgA protease (NMB0700)
and AutA (NMB0313, [72]) were up-regulated; NMB1220, a ligand
for the Macrophage Scavenger Receptor A [73,74] was up-
regulated; three putative lipoproteins (NMB1483, NMB1898 and
NMB1946) were also up-regulated including a NlpD-homologue
(NMB1483) that has been described as having a role in oxidative
damage protection in N. gonorrhoeae [75] and in the pathogenesis of
Yersinia pestis [76].
Differential expression of genes coding for vaccine
antigens against Nm
Prevention of disease caused by Nm serogroups A, C W and Y
can effectively be accomplished by vaccination. Recently, several
different protein vaccine antigens have been described for Nm
serogroup B [77]. This transcriptional analysis has the potential to
provide information about the differential regulation of the genes
coding for these vaccine antigens in response to human blood and
can be predictive for their behavior during in vivo infection. The
analysis of the dataset showed that several vaccine antigens were
differentially regulated, including NMB0035, tbpA, tbpB, lbpA, lbpB,
NMB1030, nspA, opc, NMB1946, NMB1220, NMB2091, fHbp and
porB (Table 1). Recently, a Nm serogroup B protein based vaccine
(named 4CMenB) has been developed using an in-silico genome-
based approach [78,79]. The 4CMenB vaccine contains three
main antigens: NadA, fHbp and NHBA. In the vaccine, fHbp was
fused with the protein GNA2091 and NHBA was fused with
GNA1030. We found that three out of the five genes coding for
these antigens were significantly up-regulated in human blood. As
already mentioned above, fHbp was up-regulated and also the
genes coding for GNA1030 (NMB1030) and GNA2091
(NMB2091) were highly up-regulated. The other two genes,
encoding, for NadA and NHBA, were not differently regulated
(Table 1).
Transcription of fHbp is increased during oxygen limitation,
which may be relevant in an environment like human blood [69]
where fHbp plays a protective role against complement activation.
NadA is repressed by NadR, but is de-repressed in the presence of
4-hydroxyphenylacetic acid, a metabolite of aromatic amino acid
catabolism that is secreted in saliva [80]. As such, NadA may be
induced during colonization of the nasopharynx rather than
during blood infection. This would also fit with the function of
NadA in adhesion to and invasion of the mucosal epithelium [57].
The regulation of NHBA at the molecular level is currently
unknown; however the present study suggests that NHBA
expression is not influenced by host factors present in human
blood. Little is know about the function of GNA1030 and
GNA2091. Interestingly, deletion mutants for the two genes
display equivalent or slightly reduced levels of survival with respect
to the wild-type in both human whole blood and serum [81]. It has
also been reported that a GNA2091 deletion mutant is susceptible
to membrane stresses, which the meningococcus may encounter in
the host during colonization or invasive disease [81].
Localization of proteins within the bacterial cell is an important
discriminating factor when they are evaluated as possible antigens
for a vaccine development [82]. The in silico prediction of
localization based on PSORT3 algorithm [83], and available
from PSORTdb [84], was combined with blood expression data.
In particular, the presence of relevant associations between up and
down-regulated groups and protein localization was tested. The
PSORT3 algorithm also allowed us to evaluate the presence of
specific structures like transmembrane helices and peptide motifs
like such as signal peptides. The presence of these structural
indicators was evaluated if they were significantly associated with
up and down-regulated genes. Interestingly, down-regulated genes
are only associated with cytoplasmic membrane proteins, whereas
up-regulated genes are associated with proteins located in the
periplasmic space or outer membrane (p-value ,0.05).
The information regarding the expression of Nm vaccine
antigens might give important insight into their role during Nm
growth in human blood and might help in their further functional
and immunological characterization. Moreover, the dataset of
regulated genes that was generated might facilitate the identifica-
tion of new potential vaccine antigens.
Figure 5. Transcriptional profile of Nm genes coding for
proteins involved in host-pathogen interaction. Detailed expres-
sion profile of functional genes coding for proteins that play a role in
adhesion, survival and other functions. Gene identification numbers
(based on the MC58 annotation) and gene names are reported on the
right. Genes that were calculated as being significantly regulated are
underlined. The numerical gene expression values are shown for all the
genes at the different time points.
doi:10.1371/journal.ppat.1002027.g005
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in the ex vivo blood model of infection
We hypothesized that genes with enhanced expression (up-
regulated) in response to incubation in human blood might
contribute to the survival of Nm. We selected 15 genes with a
significant and sustained increase in expression throughout the time
course of blood infection, encoding for proteins belonging to
different functional categories: transporters (tbpB, lctP), host-
pathogen interaction (opc, mip, kat, nspA), surface-exposed proteins
(nalP, NMB1483), transcriptional regulators (fur, NMB0595)a n d
hypothetical proteins (NMB1946, NMB0035, NMB1840, NMB1786,
NMB1064) (Table 2). Deletion mutants of each single gene were
generated in the Nm strain MC58 by replacing the entire encoding
sequence with an erythromycin or kanamycin resistance cassette.
The MC58 wild-type and mutant strains were then incubated in
human whole blood for two hours and samples were taken at
various time points to assess survival through CFU determination.
The fHbp mutant strain was used as a control (Figure 6A), since it
has previously been described as a crucial factor for survival in
human blood [21].
Nm MC58 mutant strains lacking LctP, TbpB, NalP, NMB1483,
Mip and Fur were sensitive to killing by human whole blood
compared to the MC58 wild-type strain (Figure 6A2–7). Bacterial
counts for the other mutants were not significantly different
compared to the MC58 wild-type strain (Figure 6A8–9), suggesting
that these genes are not essential for Nm survival in human blood in
this Nmgeneticbackground.Mutant strainswerealsocharacterized
for their growth in GC broth at 37uC in the same experimental
conditions used for incubation in blood. The growth rate for the
majority of the mutants was comparable to the wild-type strain
(insets in Figure 6A) suggesting that the phenotype observed in
blood is not attributable to a growth defect. In addition, to
overcome donor variability, we tested the same mutant strains
with a second blood donor and comparable results were obtained
(Figure S5).
LctP (NMB0543) is a lactate permease involved in the uptake of
lactate, which is present in blood and is taken up by the bacterium
as a carbon energy source and also converted to precursors of
capsular and lipopolysaccharide sialic acid [85]. The up-regulation
of lctP together with the phenotype of decreased survival that was
observed for the deletion mutants in this ex vivo model (Figure 6A2)
as well as in other relevant models [85], confirm the important role
that this membrane transporter plays in increasing complement
resistance of Nm strains. However, the fact that the lctP deletion
mutant is not completely killed in human blood even after 120
minutes of incubation might suggest that other carbon sources
could be utilized by the bacterium to generate phospho-enol
pyruvate that in turn could be used to generate sialic acid [47].
TbpA and TbpB function as the transferrin receptor in Nm
[45] and we demonstrate that a TbpB mutant is defective in
Table 1. Differential expression of genes encoding for Nm vaccine antigens.
log2
NMB Gene Annotation/Function 15 min 30 min 45 min 60 min 90 min
Up-regulated genes
NMB0035 P47, Lipoprotein 1.28 2.82 2.97 2.77 2.09
NMB0460 tbpB Transferrin binding protein B 1.04 1.53 1.47 1.13 0.96
NMB0461 tbpA Transferrin binding protein A 0.95 1.55 1.81 1.40 1.25
NMB0663 nspA Outer membrane protein 2.03 1.61 1.85 1.49 1.13
NMB1030 Hypothetical protein 1.06 1.50 1.54 1.44 1.45
NMB1053 opc Class 5 outer membrane protein 0.71 1.04 1.28 1.44 1.55
NMB1220 Outer membrane protein 0.93 1.49 1.88 1.84 2.05
NMB1540 lbpA Lactoferrin binding protein A 1.45 1.65 1.66 1.17 1.27
NMB1541 lbpB Lactoferrin binding protein B 2.30 2.33 2.50 1.98 1.89
NMB1870 fHbp factor H binding protein 0.39 0.98 1.30 1.12 1.07
NMB1946 Outer membrane lipoprotein 0.68 1.31 1.62 1.51 1.46
NMB2039 porB Porin B 20.16 1.14 1.42 0.97 0.80
NMB2091 Hypothetical protein 0.78 1.42 1.88 1.69 1.63
Down-regulated genes
NMB1985 app Adhesion and penetration protein 20.24 20.70 21.15 20.98 20.93
Not differentially regulated genes
NMB0088 Transmembrane protein 0.17 0.14 0.15 0.05 0.06
NMB0928 Putative lipoprotein 0.09 0.14 0.45 0.38 0.20
NMB0992 nhhA Neisseria hia/hsf homologue 21.18
a 21.13
a 21.15
a 20.88 20.69
NMB1429 porA Outer membrane protein PorA 20.14 0.39 0.18 0.00 0.05
NMB1988 fetA/frpB Iron-regulated outer membrane protein 0.86 0.98 0.74 0.04 20.43
NMB1994 nadA Neisseria adhesin A 20.41 20.14 0.09 0.18 0.13
NMB2132 nhba Neisserial heparin binding antigen 0.82 0.34 20.90 20.90 20.80
aRefers to expression values that do not have a significant p val (,0.05) to be considered differentially regulated.
doi:10.1371/journal.ppat.1002027.t001
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crucial step for iron-uptake and survival under these conditions
(Figure 6A3).
NalP, an autotransporter lipoprotein with serine-protease activity
that is involved inthe cleavage ofNmsurface-exposed proteins [71],
was identified as being important for survival in blood (Figure 6A4).
Studies published to date have not identified NalP as a factor
involved in the survival of Nm in the host and further study will be
necessary to understand if NalP plays a direct role in survival of Nm
(i.e., maybe by cleaving a component of the innate immune system),
or an indirect role (through activity on one of its known surface
targets). NMB1483, a putative surface-exposed lipoprotein anno-
tated as a NlpD-homologue, is also involved in survival in blood
(Figure 6A5). BLAST searches reveal that NMB1483 might have a
metalloproteaseactivityand homologuesofthisproteinareinvolved
in the pathogenesis of N. gonorrhoeae and Y. pestis [75,76].
Interestingly, in N. gonorrhoeae the NMB1483-homologue protects
against oxidative damage mediated by hydrogen peroxide and
against neutrophil-mediated killing [75].
The mip gene is highly up-regulated during blood exposure and
the results obtained with the mip deletion mutant (Figure 6A6)
suggest that the protein has a role in survival of Nm in blood. The
Mip lipoprotein is involved in the intracellular survival in
macrophages of the closely related species N. gonorrhoeae [65] and
the Nm Mip protein may also facilitate interaction of Nm with
macrophages.
The ferric uptake regulator (Fur) mutants of different pathogens
(e.g. Helicobacter pylori, Staphylococcus aureus, Listeria monocytogenes and
Campylobacter jejuni) are attenuated in animal models of infections
[86]. Similarly, our data demonstrate that in Nm Fur plays a
major role in the adaptation and survival of the bacterium in the ex
vivo model of blood infection (Figure 6A7).
As a next step in investigating the role of the up-regulated
proteins in survival in blood, we analyzed a subset of these
proteins in another genetic background. We selected the wild-
type strain 95N477, where fHbp is expressed at low levels (data
no shown) in order to investigate whether other factors that
contribute to blood survival are revealed in this strain. We
generated 95N477 deletion mutants in the genes encoding for
fHbp, LctP, TbpB, NMB1483, NspA, Kat, NMB1840,
NMB1946, NMB1786 and NMB0035, which were then tested
for survival in human whole blood (Figure 6B). In strain 95N477,
deletion of the fHbp gene did not significantly alter bacterial
survival in blood. However, deletion of NspA in strain 95N477
had a marked effect on survival in blood, suggesting that NspA
may be the main factor involved in fH binding and resistance to
the alternative complement pathway in this genetic background
where fHbp is expressed at very low levels. We did not examine
the expression of fHbp in 95N477 in blood, however, recent work
by Oriente et al. showed that fHbp is regulated in a similar
manner in 16/17 strains, in an FNR dependent manner, even in
strains with very low fHbp expression [69]. The NspA-related
phenotype observed confirms what was recently shown in NspA
mutants of a similar Nm strain with low fHbp expression [70] and
suggests that the two factors might have a complementary
function. The survival phenotypes obtained for LctP, TbpB and
NMB1483 mutants were comparable in the two genetic
backgrounds suggesting a conserved role of the function of these
proteins in the survival of Nm in blood. The other 5 mutants
analyzed in 95N477 (NMB1840, NMB1946, NMB1786, kat and
NMB0035) were not sensitive to killing by human blood and
showed comparable survivals with respect to MC58 mutants.
This suggests that, despite up-regulation of the genes, these
factors are not essential for Nm survival in human blood.
In order to better characterize mutant strains with a defective
phenotype in blood, deletion mutants for fur, mip and NMB1483 in
the MC58 genetic background and nspA in the 95N477 genetic
background were complemented. The corresponding wild-type
gene was inserted as a single copy under the control of a
constitutive promoter in the chromosome of the mutant strains
generating MCD-Cfur, MCD-Cmip, MCD-C1483 and 95D-
CnspA. Wild-type, mutant and complementing strains, were
Table 2. Nm genes up-regulated in human blood and encoding known and putative virulence factors.
log2 ratio
NMB Gene Annotation/Function 15 min 30 min 45 min 60 min 90 min
NMB0035 P47, Lipoprotein 1.28 2.82 2.98 2.77 2.09
NMB0205 fur Ferric uptake regulatory protein 0.88 1.33 1.77 1.69 1.57
NMB0216 kat Catalase 1.21 2.04 3.33 3.56 2.96
NMB0460 tbpB Transferrin binding protein B 1.04 1.53 1.47 1.13 0.96
NMB0543 lctP L-lactate permease 1.00 0.93 1.34 1.30 1.62
NMB0595 DNA-binding response regulator 0.54 1.15 1.21 1.00 0.96
NMB0663 nspA Neisseria surface protein A 2.03 1.61 1.85 1.49 1.13
NMB1053 opc Class 5 outer membrane protein 0.71 1.04 1.28 1.44 1.55
NMB1064 Conserved hypothetical protein NUDIX 1.27 1.89 2.53 2.34 2.29
NMB1483 Putative lipoprotein 0.46 0.68 1.08 0.95 1.05
NMB1567 mip Macrophage infectivity potentiator 0.42 1.51 2.21 2.03 1.60
NMB1786 Hypothetical protein 0.96 1.59 2.19 2.07 2.09
NMB1840 Conserved hypothetical protein/integral
membrane protein
0.83 1.39 2.35 2.27 2.48
NMB1946 Outer membrane lipoprotein 0.68 1.31 1.62 1.51 1.46
NMB1969 nalP Serine type peptidase 0.07 0.55 0.93 0.91 1.05
doi:10.1371/journal.ppat.1002027.t002
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shown in Figure 7, the survival in blood was restored in all the
complementing strains confirming the role played by these factors
in the survival of Nm in human blood.
Overall the mutagenesis analysis revealed a role for a subset of
the up-regulated genes, showing that a transcriptional approach
can be useful for the identification of virulence factors involved in
Nm blood survival. However, it is interesting to note that the
phenotypes of the mutants do not necessarily correlate with the
level of up-regulation of the genes considered. For example, the kat
gene had the highest level of up-regulation during the time-course
but the deletion mutants did not shown any phenotype in the ex
vivo model. Further study will be necessary to understand the
molecular mechanisms behind the phenotypes observed for the
deletion mutants analyzed in this study.
Concluding remarks
Characterization of the bacterial transcriptome during host-
pathogen interactions is a fundamental step for understanding
infectious processes caused by human pathogens. Some steps of
Nm-host interactions have been analyzed by microarray expression
profiling[8]. However, despite its importance in the disease process,
little is known about how Nm adapts to permit survival and growth
in blood.In this work,we characterized the transcriptional profile of
a Nm strain in an ex vivo human whole blood model of infection for
the first time, showing how this bacterium adapts to enable survival
and growth inblood.Nmundergoes a rapid, adaptive response and,
as a consequence, bacterial metabolism and virulence pathways are
remodeled resulting in enhanced survival, which could enable
bacterial dissemination and proliferation. A graphical summary of
our findings is shown in Figure 8, where we report a model
representing the transcriptional response of Nm genes according to
their functional class (energy metabolism, amino acid biosynthesis,
transport and binding proteins) and role in host-pathogen
interactions (adhesins, survival). We suggest that a complex
regulatory network controls the changes in expression seen upon
exposure to blood. The transcriptional and functional studies
reported in this work establish that Fur represents a major regulator
Figure 6. Survival of MC58 and 95N477 wild-type and deletion mutant strains in the ex vivo whole blood model of meningococcal
septicemia. Deletion mutants in the genetic backgrounds MC58 (panel A) and 95N477 (panel B) of the selected up-regulated genes were tested for
survival using the ex vivo whole human blood model over a time course of 120 minutes. The phenotype of the specific mutants were compared to
the wild-type strain. MCDfHbp deletion mutant was used as a control (A1). Deletion mutants with a significant sensitivity to killing by human blood
with respect to MC58 wild-type are reported in panels A2-7, while those that were not significantly sensitive are reported in panels A8-9. Deletion
mutants with a phenotype in 95N477 genetic background are reported in panels B2-5, while those that were not significantly sensitive to whole
human blood are reported in panel B6. Survival of the fHbp deletion mutant in 95N477 is reported in panel B1. The insets of each panel represent the
growth control in GC medium for the same time course of incubation as performed in whole blood.
doi:10.1371/journal.ppat.1002027.g006
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acquisition and storage are one of the main functional classes
activated in the adaptation process. Our transcriptional and
functional results suggest that Hfq and Fnr are also playing a role
in the adaptation to human blood.
Through mutagenesis studies of a subset of up-regulated
g e n e sw ew e r ea b l et oc o n f i r mt h er o l eo fp r e v i o u s l yk n o w n
virulence factors in this ex vivo model and to identify new viru-
lence factors based on their importance for bacterial survival in
human blood.
Nm usually lives as a commensal bacterium in the upper
airways of humans. Occasionally some strains can cause life-
threatening diseases such as sepsis and bacterial meningitis. It has
been proposed that differences in the pathogenic potential
between carriage and disease isolates might be influenced by
small genetic differences in genes from the core genome [6].
However, differences in the pathogenic potential of strains can be
also attributed to differences at the transcriptional level that can be
identified by performing comparative transcriptomic analyses of
different Nm strains under conditions that approximate the
human niches the bacterium encounters in vivo. Joseph et al. used
this approach to compare the transcriptional responses of two
NmB strains using a nasopharyngeal cell model of adhesion [87].
We propose that the analysis of the transcriptional response of Nm
strains using the ex vivo model of blood infection might represent a
new approach to discriminate between the virulence potentials of
different isolates.
In the field of Nm pathogenesis, this first analysis of gene
expression in blood significantly increases the knowledge of how
this bacterium responds to human blood and causes sepsis. The
findings reported in this study could also be helpful to identify the
function of gene products annotated as hypothetical proteins,
understand the regulation of vaccine antigens in blood and
ultimately develop diagnostic and therapeutic strategies to control
a devastating disease.
Materials and Methods
Ethics statement
The institutional review board of the department of health
service at Novartis Vaccines and Diagnostics (Siena, Italy)
approved the study and the use of human blood from the four
volunteers. Written, informed consent was obtained from the adult
participants.
Figure 7. Survival of MC58 and 95N477 complementing strains in the ex vivo whole blood model of meningococcal septicemia.
Results show the survival of the wild-type, deletion mutant and complementing strains in human whole blood for fur (panel 1), mip (panel 2) and
NMB1483 (panel 3) in MC58 and nspA (panel 4) in 95N477. The insets of each panel represent the growth control in GC medium for the same time
course of incubation as performed in whole blood.
doi:10.1371/journal.ppat.1002027.g007
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Serogroup B Nm strains (MC58, 95N477 and their isogenic
derivatives) and Escherichia coli DH5a strains used in this study are
listed in Table S5. Nm strains were grown on GC agar plates or in
GC broth at 37uCi n5 %C O 2. E. coli strains were cultured in Luria-
Bertani(LB)agarorLBbrothat37uC.Antibioticswereaddedwhen
required; erythromycin and chloramphenicol were added at final
concentration of 5 mg/ml for selection of deletion mutants and
complementing strains, respectively. Ampicillin and erythromycin
were added at final concentration of 100 mg/ml for E. coli.
For microarray analysis of Nm in whole blood, MC58 Nm
strains were grown overnight on GC agar plates and cultured in
GC broth to early exponential phase. Approximately 10
8 bacteria
were pelleted by centrifugation at 4000 rpm for 5 minutes and
resuspended in an equal volume (1 ml) of freshly isolated human
blood maintained at 37uC. Whole blood infected with bacteria was
incubated for 0, 15, 30, 45, 60 and 90 minutes with gentle
shacking to avoid sedimentation. Samples were then treated with
RNA protect bacteria reagent (Qiagen) immediately after adding
bacteria to whole blood (time 0) and for each time point to 90
minutes. Cells were harvested by centrifugation and stored at
280uC until bacterial RNA isolation. Each time point was
represented by three samples from which RNA was purified
separately. CFU counts were obtained for Nm cultures immedi-
ately before time course initiation (time 0) and after 30, 60 and 90
minutes of incubation. The time course experiments were
performed independently with four different blood donors.
For microarray analysis of Nm in GC broth medium, MC58
strain was grown and treated as described above for microarray
analysis in whole blood. Briefly, approximately 10
8 bacteria were
resuspended in an equal volume (1 ml) of GC broth medium
containing heparin at final concentration of 5 U/ml. Bacteria
were incubated for 0, 30, 60 and 90 minutes. Samples were then
treated as described above. Each time point was represented by
three samples from which RNA was purified separately. CFU
counts were obtained, immediately before time course experiment
(time 0) and at 30, 60 and 90 minutes. This time course
experiment was performed in duplicate with two different bacterial
growths.
Human whole blood
Heparinized human venous blood was collected from 4 healthy
volunteers (two males and two females, ages ranged from 25 to 35
years). Heparin was used at concentration of 5 U/ml. Heparin was
used in preference to ethylenediaminetetraacetic acid (EDTA) as an
anti-coagulant agent because EDTA chelates divalent cations,
which would influence cellular functions during Neisseria-blood cell
interactions.Heparin iscommonly usedinbloodmodels ofinfection
for Neisseria [11,19], and while heparin has been reported to affect
complement activation, it is not known to alter gene expression in
Neisseria.
Isolation and enrichment of bacterial RNA
For RNA isolation, the samples were incubated with 5 volumes
of Erythrocyte Lysis (EL) buffer (Qiagen) for 15 minutes on ice and
centrifuged at 4uC and 4500 rpm for 6 minutes. Total RNA
(bacterial and eukaryotic RNA) was isolated by enzymatic lysis
using lysozyme (Sigma) at 0.4 mg/ml final concentration, vortexed
Figure 8. Schematic overview of the factors involved in adaptation and survival of Nm in human blood. The model presents the
transcriptional response of Nm genes according to their functional classes (TIGRFAM main roles: energy metabolism, amino acid biosynthesis,
transport and binding proteins and regulatory functions) and genes coding for factors involved in host-pathogen interactions (adhesins, survival). The
pathways and specific genes mentioned in the results and discussion section are reported. Colors indicate up-regulated genes (red), down-regulated
genes (green) and not differentially regulated genes (grey).
doi:10.1371/journal.ppat.1002027.g008
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was completed with the RNeasy Mini Kit (Qiagen) according to
the manufacturer’s protocol. DNA contamination was avoided by
on-column treatment and post-treatment with RNase-Free DNase
Set (Qiagen). Absence of bacterial DNA was confirmed by PCR
with primers specific for NMB0992. RNA concentration and
integrity was assessed by measurement of the A260/A280 ratios
and electrophoretic analysis with an Agilent 2100 Bioanalyzer
(Agilent Technologies).
Finally, three total RNA aliquots corresponding to each time
point were pooled and used for the bacterial RNA enrichment
procedure. Enrichment of bacterial RNA was performed using the
MICROBEnrich kit (Ambion) according to manufacturer’s
instructions. The percentage of enrichment of bacterial RNA
from the initial total RNA mixture (eukaryotic and bacterial RNA)
was reproducible between the different independent experiments
performed (single donors) and was usually around 10%. Enriched-
bacterial RNA was assessed by electrophoretic analysis with an
Agilent 2100 Bioanalyzer. The absence of eukaryotic nucleic acids
was confirmed by PCR and RT-PCR with primers specific for the
actB human gene. Enriched-bacterial total RNA was used as
template for cRNA synthesis (amplification and labeling reaction)
and also for validation of microarray data by qRT-PCR.
RNA amplification and labeling
Enriched-bacterial RNA was amplified and labeled using the
MessageAmp II Bacteria kit (Ambion). The kit employs an in vitro
transcription (IVT)-mediated linear amplification system to
produce amplified RNA (cRNA). Briefly, 100 ng of total RNA
from each time point was used as template for the synthesis
reaction. An initial polyadenylation step was performed. The
tailed RNA was reverse transcribed (cDNA synthesis) in a reaction
primed with oligo (dT) primers bearing a T7 promoter. The
resulting cDNA was then transcribed with T7 RNA Polymerase to
generate antisense RNA (cRNA) in an in vitro reaction for 14 hours
at 37uC. The cRNA was labeled by including Cyanine 3-CTP
(Cy3) and Cyanine 5-CTP (Cy5; Perkin Elmer, Boston, MA)
nucleotides in the IVT reaction.
The cRNA was then fragmented in fragmentation buffer
(Agilent Technologies) at 60uC for 30 minutes before hybridiza-
tion. Competitive hybridizations were conducted with 500 ng of
Cy3-labelled cRNA reference (bacteria in contact with whole
blood at time 0) versus 500 ng Cy5-labelled cRNA of each time
point (15, 30, 45, 60 and 90 minutes). cRNAs were hybridized
onto the microarray slides for 17 hours at 65uC, washed and
scanned with an Agilent scanner following the Agilent Microarray
protocol.
Microarray design and analysis
Gene expression analysis was performed using an Agilent
custom-designed 60-mer oligonucleotide microarray. Probes were
designed to cover the complete annotated genes of Nm MC58
strain, except for 80 genes that for cross-homology reasons it was
not possible to design specific probes and the final resulting
coverage is 96.2% (2078/2158 genes). Probe design was per-
formed respecting oligonucleotide sequence specificity, structural
and thermodynamic constraints [88,89] in order to obtain at least
two probes for each open reading frame of the genome. For some
specific genes we covered in tiling the entire open reading frames
(fHbp, nadA, nhba, NMB1030, NMB2091). Two probes for each of
the previous selected genes together with the seven multi locus
typing housekeeping genes, abcZ, adk, aroE, fumC, gdh, pdhC and pgm
were used for the design of 21 and 5 replicas randomly distributed
on the surface of the chip to have control spots of the signal
uniformity within each sample. The chip layout was submitted to
the EBI ArrayExpress and it is available with the identifier A-
MEXP-1957.
Normalization was performed with the application BASE [90]
using an intra-slide median centering after a low intensity spot
correction (if the average spot intensity, background subtracted, is
less than one standard deviation of the background signal the
intensity spot was corrected to the same value of one standard
deviation of the background signal).
Differentially expressed genes were assessed by grouping, at
each time point independently, all log2 ratio values corresponding
to each gene, within experimental replicas and spot replicas, and
comparing them against the zero value by Student’s t-test statistics
(one tail). We usually accept as differentially expressed those genes
having a t-test p-value ,0.05 in at least one time point. We also
applied a log2 ratio threshold filtering in the same time point,
accepting values .1o r,21. The threshold is inferred from log2
ratio distributions widths (standard deviation between 0.77 and
1.60 and an average of 1.08) observed in each sample at time
points from 15 to 90 minutes. Multiple testing problem and Type I
error rate control was done by false discovery rate (FDR) statistics
based on the estimation of the q-values for each t-test [91].The
previous criterion to define differentially expressed genes was
compared with the results obtained with BETR [92], a Bayesian
statistical method specifically developed to assess differentially
expressed genes during a time course experiment.
Clustering and enrichment analysis
The Figure Of Merit (FOM) [29] analysis is a quantitative
method to establish the internal quality of clusters inferred with a
defined clustering algorithm. In particular the FOM algorithm
assesses the quality of the clustering by a jackknife approach
removing one experiment ‘e’ at a time from the dataset, clustering
gene profiles for the remaining experiments and evaluating the
root mean square deviation in the left-out condition ‘e’ of the
individual gene expression levels relative to their cluster means.
See references [29,93] for further details. We measured the
aggregate adjusted FOM for different clustering algorithms as
implemented by the R package clValid applied to the averaged
expression profiles of the 637 genes that we selected as regulated.
Hierarchical, Self Organizing Tree Algorithm (SOTA), Partition-
ing Around Medoids (PAM) and K-means clustering algorithms,
applied as described below, were compared and FOM was plotted
as a function of the increasing number of clusters. When the
number of clusters increases, FOM tends to decrease and stabilize
to a plateau. Better clustering is obtained using algorithms that
reach this plateau faster.
Hierarchical clustering was applied as implemented by hclust in
the R package stats using the Euclidean metrics and the average
agglomeration method.
The SOTA was applied as implemented by the same R package
clValid, also based on the Euclidean metrics with unchanged
default parameters.
The PAM method was applied as implemented by the R package
cluster with Euclidean metrics and default parameters.
K-means clustering was applied as implemented by the R
packages clValid and stats with Euclidean metrics and default
parameters.
Enrichment analysis was performed by Fisher’s exact test and
Benjamini-Hochberg correction as implemented by the Multi-
Experiment Viewer TMEV [94] testing whether the list of genes
up/down regulated or belonging to a specific cluster was
particularly rich, with respect to a random distribution, of genes
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qRT-PCR analysis and normalization
The microarray data was validated by two-step qRT-PCR for
nine differentially regulated genes for one time point (45 minutes)
for each single donor. Primers for genes NMB0995, NMB1030,
NMB1541,NMB1567,NMB1870,NMB1898,NMB1946,NMB2091
and NMB2132 are reported in Table S3. They were designed using
the Primer3 program and primer specificity was controlled
following the denaturing protocol of the MX3000P Real Time
PCR system Software version 2.0. Standard curves were performed
using genomic DNA from Nm to measure primer pair efficiency.
Specificity of all amplicons was confirmed by melting curves and
gel analysis. For analysis of in vitro transcripts derived from Nm
growth in human whole blood, cDNA synthesis was primed using
500 ng of total RNA, random hexamer primers (Promega) and
SuperScript II (Invitrogen) according to the manufacturer’s
instructions.
Fluorescence PCR amplifications were performed using 1 ml
aliquot of each first strand cDNA reaction with Brilliant SYBR
Green QPCR Master mix (Stratagene) on a Mx3000P cycler
(Stratagene) in a final volume of 25 ml. The qRT-PCR reactions
were performed in triplicate for the four biological replicates. To
normalize the data, 16S rRNA was used as an endogenous control,
which is transcribed at constant levels. Relative quantification was
performed using the 2
(-DDCt) method, including an efficiency
correction for the primers using the Relative Expression Software
Tool (REST).
Construction of isogenic deletion mutants and
complementing strains
To generate isogenic deletion mutants, target genes were
truncated by replacing the gene sequence with an erythromycin
(Ery) or kanamycin (Kan) resistance cassette. Approximately 800
bp fragments of the flanking regions of target genes were amplified
by PCR from Nm MC58 genomic DNA. Primers used for
generation of flanking regions are listed in Table S3. Upstream
regions were generated with XbaI and SmaI restriction sites, while
downstream regions with SmaI and XhoI restriction sites.
Restriction enzymes were purchased from New England Biolabs.
The purified PCR fragments were digested and co-ligated into the
pBluescript (pBS-KS vector) (Novagen) and transformed into E.
coli DH5-a using standard techniques. Resulting plasmids were
digested with SmaI to insert the erythromycin or kanamycin
cassette. All constructs generated to delete the target genes are
listed in Table S4. Once subcloning was complete, plasmid DNA
was linearized using ApaI and naturally competent Nm MC58
and 95N477 strains were transformed. Transformants were then
selected on plates containing erythromycin at 5 mg/ml or
kanamycin at 100 mg/ml. Deletion of the target gene was verified
by colony PCR analysis using primer pairs to amplify a PCR
product inside each gene locus (Table S3). In addition, the primers
1 and 2 (Figure S4A and Table S3) were used to confirm, by
sequencing, the correct insertion and orientation of antibiotic
resistance cassettes within the deletion region. Furthermore, the
sequencing permitted verification that there were no variations in
the sequences of the adjacent genes (used as flanking regions) due
to the recombination event. The amplified PCR fragments were
sequenced using the primers 1 and 2 specific for each gene region
and the primers 3 and 4 specific for the antibiotic cassette used to
generate the KO strains (Kan or Ery) (Figure S4A and Table S3).
Southern blots analysis was performed to verify that all the
deletion mutants have no off-target insertions of the antibiotic
resistance cassettes.
The various deletion mutant strains were also analyzed
for growth kinetics in GC broth with respect to the wild-
type strains.
The genes to be complemented were cloned into the pCom-
pRBS vector [95]. Forward primers include a NdeI restriction site
and reverse primers contain a NsiI restriction site. The pairs of
primers used to amplify the different genes are indicated in Table
S3. PCRs were performed on Nm MC58 (for genes: NMB1483
and mip) or 95N477 (for gene nspA) genomic DNA using the
Platinum Taq High Fidelity DNA polymerase (Invitrogen). Each
PCR product was digested with NdeI and NsiI enzymes, and
cloned into the NdeI/NsiI sites of the pCom-pRBS vector.
Resulting plasmids were checked by sequencing and are listed in
Table S5. Plasmid DNA was linearized using SpeI and used to
transform respective isogenic deletion mutants. The genes were
inserted in the intergenic region between the NMB1428 and
NMB1429 genes and the recombination event occurs between the
upstream and downstream region of this locus, allowing the
insertion of chloramphenicol resistance cassette and the gene of
interest under the control of a constitutive promoter. Transfor-
mants were then selected on plates containing chloramphenicol at
5 mg/ml and insertion of the target gene was verified by colony
PCR using primers designed on the regions flanking the site of
recombination as previously described [95].
The various deletion mutant and complementing strains were
also analyzed for growth kinetics in GC broth with respect to the
wild-type strains.
Southern blot analysis
Genomic DNA of Nm wild-type and deletion mutant strains
were isolated using Dneasy blood and tissue extraction kit (Qiagen)
according to the manufacturer’s instructions. Two mg of genomic
DNA was digested with BglI overnight and purified using a PCR
purification kit (Qiagen). Southern Blot was performed using the
ECL Direct Nucleic Acid Labeling and Detection Systems (GE
Healthcare) according to the manufacturer’s instructions. Briefly,
digested DNA was separated in a 0.8% agarose gel and blotted to
Hybond N+ membrane (Amersham). The blots were hybridized
with the probes generated by PCR using High Fidelity DNA
Polymerase (Invitrogen) and labeled with HRP (horseradish
peroxidase). The probes were a 1019 bp-Kan (amplified using
the primers SB_Kan Fw and SB_Kan Rv) or a 1018 bp Ery
fragment (amplified using the primers SB_Ery Fw and SB_Ery Rv)
(Table S3).
Ex vivo whole blood model of meningococcal
bacteremia
Nm MC58 and 95N477 wild-type, deletion mutants and
complementing strains were grown on GC agar plates at 37uC
overnight. Bacteria were harvested into GC liquid medium to an
OD=600 nm of 0.05 and grown to mid-log phase (OD 0.5-0.6)
then diluted to approximately 10
6,1 0
5 or 10
4 CFU/ml in a total
volume of 100 ml of GC liquid medium in a 96 well/plate. The
assay was started by the addition of 100% whole human blood
(190 ml), supplied by two different donors (a male and a female) to
the bacterial suspension (10 ml) in a 96 well/plate. Cultures were
incubated at 37uC/5%CO2 with gentle agitation, at various time
points (30, 60 and 120 minutes) an aliquot of the sample was
removed and the number of viable bacteria determined by plating
serial dilutions onto MH agar and incubating overnight at 37uC/
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diluted 100 ml culture as the control time 0 (T0). Whole venous
blood, collected from healthy individuals and anti-coagulated with
heparin (5 U/ml), was used for whole blood experiments [11,19].
Supporting Information
Figure S1 Statistical analysis of the correlation between donor
samples. (A) Top panel, distribution of Pearson correlation rijg of
gene expression profiles (g) between donor samples i and j bottom
panel, the same distribution results shown as a box-plot. Typically
genes show a good reproducibility (3/4 of the comparisons have r
. 0.6). (B) Same analysis as performed in A but comparing pairs of
data sets between the single blood donors shown in single box-
plots. (C) Quartile statistics values are reported in the table for
pairs of donors shown in panel B.
(TIF)
Figure S2 Validation of microarray data by qRT-PCR. (A)
Comparison of microarray (white bars) and qRT-PCR (black bars)
fold change results for 9 selected genes. Fold change qRT-PCR
ratios represent the difference in transcript abundance/signal for
these genes after 45 minutes of incubation in human whole blood
as compared to time 0. qRT-PCR normalization data was done
using 16S rRNA as a reference gene. The qRT-PCR and
microarray data are represented as the mean of gene expression of
four independent experiments. (B) Correlation analysis of micro-
array and qRT-PCR transcript measurements for the nine selected
genes shown in panel A. The qRT-PCR and microarray log2
values were plotted and the coefficient of correlation was
calculated, r = 0.98.
(TIF)
Figure S3 Distribution of differentially regulated genes within
TIGRFAM sub-roles and KEGG pathways. (A) TIGR families
sub-roles and (B) KEGG pathways. The groups with five or more
differentially regulated genes are represented. Darker bars indicate
the most relevant enrichments among the included groups (Fisher s
exact test p-value , 0.05).
(TIF)
Figure S4 Characterization of the Nm deletion mutants. (A)
Schematic representation of the allelic replacement with the
resistance cassette, used to generate the deletion mutant strains.
The gene locus of each deletion mutant was amplified from the
genomic DNA using primers specific for each amplicon (indicated
as 1 and 2) and the PCR fragments were sequenced using the same
primers and primers 3 and 4 for the antibiotic cassette Kan or Ery.
(B) The orientation of the resistance cassette for each deletion
mutant, determined from sequencing. C. Southern blot analysis
was performed using labeled Kan and Ery PCR products as
probes. Genomic DNA of wild-type and deletion mutant strains
was digested with BglI. The size of the expected fragment for each
mutant is reported in panel B. The length of the fragment is
approximate since the BglI restriction site is subjected to dam
methylation that could occur along the genomic DNA.
(EPS)
Figure S5 Survival of MC58 wild-type and deletion mutant
strains in the ex vivo whole blood model using a second blood
donor. Deletion mutants of the selected up-regulated genes were
tested for survival using the ex vivo whole human blood model over
a time course of 120 minutes. In each panel the phenotype of the
specific mutant is compared to MC58 wild-type strain. The
MCDfHbp deletion mutant was used as a control. The insets of
each panel represent the growth control in GC medium for the
same time course of incubation as done with whole blood.
(TIF)
Table S1 List of genes belonging to the different K-means
partitioning clusters and TIGRFAMs main roles. Provided as an
Excel file.
(XLS)
Table S2 Significant correlation (Fisher s exact test p-value ,
0.05, underlined if significant with Benjamini-Hochberg correc-
tion) between K-means partitioning clusters and TIGRFAM main
roles and KEGG pathways. Provided as an Excel file.
(XLS)
Table S3 Primers used in this study.
(DOC)
Table S4 Plasmids used in this study.
(DOC)
Table S5 Nm wild-type, deletion mutants and complementing
strains used in this study.
(DOC)
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